NORA SAUL

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NEW BRAUNFELS, TX NPI 1801132014

General Payments — all program years on this page

$7,356.99

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 333
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $591.28 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $591.2819

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $140.187
Medtronic, Inc. $104.001
Janssen Biotech, Inc. $89.371
ARGENX US, INC. $81.431
Abbott Laboratories $79.154
ABBVIE INC. $64.003
GE HEALTHCARE $18.681
Lundbeck LLC $14.471

By program year

Program yearAmountRecords
2021 $1,766.4785
2022 $2,286.48107
2023 $2,712.76122
2024 $591.2819

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078766392 Janssen Biotech, Inc. $89.37 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108147655 ABBVIE INC. $34.33 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108147657 ABBVIE INC. $14.24 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108147659 ABBVIE INC. $15.43 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116993370 Medtronic, Inc. $104.00 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125278511 Abbott Laboratories $26.64 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125278513 Abbott Laboratories $20.45 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125278515 Abbott Laboratories $16.39 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125278517 Abbott Laboratories $15.67 12/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142148592 ARGENX US, INC. $81.43 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144683074 GE HEALTHCARE $18.68 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146086444 Lundbeck LLC $14.47 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151590046 Teva Pharmaceuticals USA, Inc. $8.88 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151590050 Teva Pharmaceuticals USA, Inc. $10.80 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151590054 Teva Pharmaceuticals USA, Inc. $7.71 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151590106 Teva Pharmaceuticals USA, Inc. $11.46 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151590113 Teva Pharmaceuticals USA, Inc. $71.32 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151590124 Teva Pharmaceuticals USA, Inc. $15.65 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151590128 Teva Pharmaceuticals USA, Inc. $14.36 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.